HK1213740A1 - 製備抗癌症組合物的方法 - Google Patents

製備抗癌症組合物的方法

Info

Publication number
HK1213740A1
HK1213740A1 HK16101956.2A HK16101956A HK1213740A1 HK 1213740 A1 HK1213740 A1 HK 1213740A1 HK 16101956 A HK16101956 A HK 16101956A HK 1213740 A1 HK1213740 A1 HK 1213740A1
Authority
HK
Hong Kong
Prior art keywords
methods
cancer compositions
making cancer
making
compositions
Prior art date
Application number
HK16101956.2A
Other languages
English (en)
Inventor
John K Lynch
Jeffrey J Hutchison
Xiong Fu
Kevin Kunnen
Original Assignee
Genspera Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genspera Inc filed Critical Genspera Inc
Publication of HK1213740A1 publication Critical patent/HK1213740A1/zh

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C227/00Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C227/14Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton from compounds containing already amino and carboxyl groups or derivatives thereof
    • C07C227/16Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton from compounds containing already amino and carboxyl groups or derivatives thereof by reactions not involving the amino or carboxyl groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/93Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems condensed with a ring other than six-membered
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365Lactones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/62Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
    • A61K47/64Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C227/00Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C227/02Formation of carboxyl groups in compounds containing amino groups, e.g. by oxidation of amino alcohols
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C227/00Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C227/14Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton from compounds containing already amino and carboxyl groups or derivatives thereof
    • C07C227/18Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton from compounds containing already amino and carboxyl groups or derivatives thereof by reactions involving amino or carboxyl groups, e.g. hydrolysis of esters or amides, by formation of halides, salts or esters
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/02Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C229/04Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C229/06Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton
    • C07C229/08Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton the nitrogen atom of the amino group being further bound to hydrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C269/00Preparation of derivatives of carbamic acid, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C269/04Preparation of derivatives of carbamic acid, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups from amines with formation of carbamate groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C269/00Preparation of derivatives of carbamic acid, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C269/06Preparation of derivatives of carbamic acid, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups by reactions not involving the formation of carbamate groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C271/00Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C271/06Esters of carbamic acids
    • C07C271/08Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
    • C07C271/10Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C271/22Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of hydrocarbon radicals substituted by carboxyl groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06Dipeptides
    • C07K5/06104Dipeptides with the first amino acid being acidic
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06Dipeptides
    • C07K5/06104Dipeptides with the first amino acid being acidic
    • C07K5/06113Asp- or Asn-amino acid
HK16101956.2A 2013-03-15 2016-02-23 製備抗癌症組合物的方法 HK1213740A1 (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201361791909P 2013-03-15 2013-03-15
PCT/US2014/029674 WO2014145035A1 (en) 2013-03-15 2014-03-14 Methods of making cancer compositions

Publications (1)

Publication Number Publication Date
HK1213740A1 true HK1213740A1 (zh) 2016-07-15

Family

ID=51537866

Family Applications (1)

Application Number Title Priority Date Filing Date
HK16101956.2A HK1213740A1 (zh) 2013-03-15 2016-02-23 製備抗癌症組合物的方法

Country Status (15)

Country Link
US (3) US9446141B2 (zh)
EP (1) EP2967072A4 (zh)
JP (1) JP2016518339A (zh)
KR (1) KR20150132225A (zh)
CN (1) CN105722394A (zh)
AU (1) AU2014233421A1 (zh)
BR (1) BR112015023088A2 (zh)
CA (1) CA2903599A1 (zh)
CL (1) CL2015002584A1 (zh)
EA (1) EA201591449A1 (zh)
HK (1) HK1213740A1 (zh)
IL (1) IL241149A0 (zh)
MX (1) MX2015012523A (zh)
SG (1) SG11201506953RA (zh)
WO (1) WO2014145035A1 (zh)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2903599A1 (en) * 2013-03-15 2014-09-18 Genspera, Inc. Methods for making cancer compositions
TW201618768A (zh) * 2014-11-18 2016-06-01 琴史匹亞公司 製造前藥及靶定治療性化合物之方法
KR20200028399A (ko) 2017-07-13 2020-03-16 후지세유 그룹 혼샤 가부시키가이샤 펩타이드

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5948919A (en) * 1993-02-05 1999-09-07 Napro Biotherapeutics, Inc. Paclitaxel synthesis from precursor compounds and methods of producing the same
US6504014B1 (en) * 1997-05-19 2003-01-07 The John Hopkins University Tissue specific prodrug
US7468354B2 (en) * 2000-12-01 2008-12-23 Genspera, Inc. Tissue specific prodrugs
US9107863B2 (en) * 2006-03-27 2015-08-18 The Buck Institute For Age Reasearch Reagents and methods for cancer treatment and prevention
EP2391361A1 (en) * 2009-02-02 2011-12-07 Martek Biosciences Corporation Methods for improving cognitive function and decreasing heart rate
WO2010107909A2 (en) * 2009-03-17 2010-09-23 The Johns Hopkins University Methods and compositions for the detection of cancer
CA2903599A1 (en) * 2013-03-15 2014-09-18 Genspera, Inc. Methods for making cancer compositions

Also Published As

Publication number Publication date
KR20150132225A (ko) 2015-11-25
SG11201506953RA (en) 2015-10-29
WO2014145035A1 (en) 2014-09-18
US20160347706A1 (en) 2016-12-01
EA201591449A1 (ru) 2016-04-29
EP2967072A4 (en) 2016-11-16
US20160347730A1 (en) 2016-12-01
BR112015023088A2 (pt) 2017-11-21
US9822064B2 (en) 2017-11-21
CN105722394A (zh) 2016-06-29
AU2014233421A1 (en) 2015-09-24
CA2903599A1 (en) 2014-09-18
CL2015002584A1 (es) 2016-02-26
US9446141B2 (en) 2016-09-20
IL241149A0 (en) 2015-11-30
US20160030589A1 (en) 2016-02-04
JP2016518339A (ja) 2016-06-23
MX2015012523A (es) 2016-04-26
US9845283B2 (en) 2017-12-19
EP2967072A1 (en) 2016-01-20
WO2014145035A8 (en) 2016-04-14

Similar Documents

Publication Publication Date Title
GB201421334D0 (en) Synthesis of aeizeolite
GB201304662D0 (en) Compositions
HK1220737A1 (zh) 短端粒丰度的量度
GB201608461D0 (en) Compositions
GB201507664D0 (en) Composition & methods of screening
GB201319531D0 (en) Composition & methods of screening
GB201300569D0 (en) Ferrite compositions
HK1213740A1 (zh) 製備抗癌症組合物的方法
GB201607581D0 (en) Treatment of cancer
HRP20182110T1 (hr) Sastav spojeva tiakumicina
ZA201505650B (en) New compositions
HK1232118A1 (zh) 癌症的治療
HK1215390A1 (zh) 結直腸癌的模型
GB201320962D0 (en) Compositions
HK1216419A1 (zh) 合成方法
EP3043646A4 (en) Methods of making 2-halonicotinonitriles
GB201320959D0 (en) Compositions
PL3071575T3 (pl) Wytwarzanie normorfinanów
HK1198422A1 (zh) 羊毛固醇三萜的新穎用途
GB201316438D0 (en) Interconnection of parts
GB201315461D0 (en) Composition of phosphonates
GB201322347D0 (en) Treatment of cancer
GB201318742D0 (en) Treatment of cancer
GB201312224D0 (en) Compositions
GB201308529D0 (en) Treatment of cancer